CN114585356A - 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法 - Google Patents

预防或治疗与vegfr和/或vegf被抑制相关疾病的方法 Download PDF

Info

Publication number
CN114585356A
CN114585356A CN202080072302.3A CN202080072302A CN114585356A CN 114585356 A CN114585356 A CN 114585356A CN 202080072302 A CN202080072302 A CN 202080072302A CN 114585356 A CN114585356 A CN 114585356A
Authority
CN
China
Prior art keywords
inhibitor
vegfr
vegf
administration
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080072302.3A
Other languages
English (en)
Inventor
张诗宜
吴兆宇
陈乐颖
陈玉云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Ankao Pharmaceutical Technology Co ltd
Original Assignee
Shanghai Ankao Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Ankao Pharmaceutical Technology Co ltd filed Critical Shanghai Ankao Pharmaceutical Technology Co ltd
Publication of CN114585356A publication Critical patent/CN114585356A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

涉及硝基化合物在制备药物中的新用途，所述药物用于预防或治疗与施用VEGFR抑制剂和/或VEGF抑制剂相关的疾病或病症。还提供预防或者治疗与施用VEGFR抑制剂和/或VEGF抑制剂相关的包含本申请所述化合物的药物组合或试剂盒。还提供了一种预防或治疗疾病或病症的方法，其包括监测被施用VEGFR抑制剂和/或VEGF抑制剂的受试者的一种或多种皮肤组织、五官和/或胃肠道特征，当所述监测显示到疾病或病症时，向所述受试者施用所述的化合物。

Description

PCT国内申请，说明书已公开。

Claims (71)

  1. PCT国内申请，权利要求书已公开。
CN202080072302.3A 2019-10-16 2020-10-14 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法 Pending CN114585356A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201910983799 2019-10-16
CN2019109837993 2019-10-16
PCT/CN2020/120916 WO2021073535A1 (zh) 2019-10-16 2020-10-14 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法

Publications (1)

Publication Number Publication Date
CN114585356A true CN114585356A (zh) 2022-06-03

Family

ID=75538459

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080072302.3A Pending CN114585356A (zh) 2019-10-16 2020-10-14 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法

Country Status (2)

Country Link
CN (1) CN114585356A (zh)
WO (1) WO2021073535A1 (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425658D0 (en) * 2004-11-22 2004-12-22 Stanford Rook Ltd Immunotherapeutic agent
EP2805730A1 (en) * 2013-05-21 2014-11-26 Bergen Teknologioverforing AS Nitric oxide donor for the treatment of chronic fatigue syndrome
WO2014197847A1 (en) * 2013-06-07 2014-12-11 The Regents Of The University Of California Methods and systems of treating wounds
TW201943428A (zh) * 2018-04-16 2019-11-16 大陸商上海岸闊醫藥科技有限公司 預防或治療腫瘤療法副作用的方法

Also Published As

Publication number Publication date
WO2021073535A1 (zh) 2021-04-22

Similar Documents

Publication Publication Date Title
JP7262508B2 (ja) 癌を治療するための方法
JP7520366B2 (ja) 腫瘍療法の副作用の予防または治療方法
JP7445893B2 (ja) ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ
BR112019024135A2 (pt) Terapias de combinação para o tratamento de câncer
KR20200067164A (ko) 조합 요법 및 그의 용도
ES2641864T3 (es) Terapia de combinación de un inhibidor de MEK y un inhibidor de IGF1R
WO2022143628A1 (zh) 预防或治疗抗肿瘤剂相关疾病或病症的方法
MX2014010591A (es) Terapia combinada para el tratamiento de cancer de ovario.
CN112672739A (zh) 治疗癌症的方法
CN113811298B (zh) 用于联合治疗小细胞肺癌的喹啉衍生物
US10583111B2 (en) Method for preventing or treating diseases associated with the inhibition of EGFR
RU2764175C1 (ru) Бифункциональные композиции для лечения рака
JP7516336B2 (ja) チロシンキナーゼ阻害剤と併用してｅｇｆ／ｅｇｆｒ経路を抑制する方法および組成物
CN116669765A (zh) 预防或治疗egfr功能异常相关的副作用的方法
CN114585356A (zh) 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法
WO2023142996A1 (zh) 预防或治疗与抗肿瘤剂相关的疾病或病症的方法
CN116211789A (zh) 组合物及其用途
RU2782033C2 (ru) Способ профилактики или лечения побочного эффекта опухолевой терапии
US20210145811A1 (en) Treatment of cancer with exon 14 skipping mutation(s) or exon 14 skipping phenotype
US20220363776A1 (en) Methods and pharmaceutical composition for the treatment of ovarian cancer, breast cancer or pancreatic cancer
WO2024102968A1 (en) Uses of ep2/ep4 antagonist compounds for treating familial adenomatous polyposis (fap)
WO2024019976A1 (en) Methods for treating cancer including glatiramer acetate and immune checkpoint inhibitors

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40069551

Country of ref document: HK